Showing results (1761-1770 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|September 2, 1999
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysisF C Ebeling, U M Schmitt, M Untch, et al.Anticancer Research|September 2, 1999
Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancerW Heyl, J M Wolff, S Biesterfeld, et al.Anticancer Research|September 2, 1999
The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinomaG M Oremek, S Teigelkamp, W Kramer, et al.Anticancer Research|September 2, 1999
Estimation of total PSA with a supersensitive PSA-assay during neo-adjuvant-chemotherapy of prostate cancer before radical resection of prostateJ Spitz, T Enzmann, W Müller, et al.Anticancer Research|September 2, 1999
Serum concentrations of transforming growth factor-beta 1 in patients with benign and malignant prostatic diseasesJ M Wolff, T H Fandel, H Borchers, et al.Anticancer Research|September 2, 1999
Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomasP Stieber, H Dienemann, A Schalhorn, et al.Anticancer Research|September 2, 1999
CYFRA 8/18 in head and neck cancerJ D Maass, A M Niemann, B M Lippert, et al.Anticancer Research|September 2, 1999
Thyroid peroxidase (TPO) as a tumor marker in the follow-up of differentiated thyroid carcinomas with surgical and ablative radioiodine therapy. An assessment after evaluationW G Franke, K Zöphel, G Wunderlich, et al.Anticancer Research|September 2, 1999
Persistent elevation of CA 19-9 levels in a patient with an extended retroperitoneal dermoidO Micke, U Schafer, N WillichAnticancer Research|September 2, 1999
Apoptosis in serum of patients with solid tumoursS Holdenrieder, P Stieber, T Förg, et al.Pageof 2,589